New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
ETF Central logo
Advertisement

PSCHvsXPHETF Comparison

ETF 1
PSCH

Invesco S&P SmallCap Health Care ETF

This fund is part of
US Health Care
-0.31%
Full PSCH fund page
VS
ETF 2
XPH

SPDR S&P Pharmaceuticals ETF

This fund is part of
US Health Care
-0.31%
Full XPH fund page

Invesco S&P SmallCap Health Care ETF (PSCH) and SPDR S&P Pharmaceuticals ETF (XPH) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. PSCH is less expensive with a Total Expense Ratio (TER) of 0.29%, versus 0.35% for XPH. PSCH is down -6.58% year-to-date (YTD) with -$14M in YTD flows. XPH performs better with -1.12% YTD performance, and +$88M in YTD flows. Run a side-by-side ETF comparison of PSCH and XPH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

PSCH vs XPH performance and flow charts

Performance

-5.0-4.0-3.0-2.0-1.00.01.02.0%Feb 11Feb 19Feb 26Mar 5

Cumulative Flows

-10 M-5 M0 M5 M10 M15 MFeb 11Feb 19Feb 26Mar 5

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 03/11/2026
1M3MYTD1Y3Y5Y
Perf.
PSCH
XPH
-4.72%-3.45%
-11.03%-1.36%
-6.58%-1.12%
-2.86%+29.22%
-2.42%+42.98%
-34.70%+9.16%
Flows
PSCH
XPH
-$12M+$12M
-$15M+$95M
-$14M+$88M
-$33M+$111M
-$168M+$48M
-$230M+$36M
Volatility and drawdown
3M1Y3Y5Y
Volatility
PSCH
XPH
+18.03%+20.33%
+23.00%+23.08%
+21.45%+19.01%
+22.75%+20.26%
Max drawdown
PSCH
XPH
-11.08%-5.97%
-13.37%-17.10%
-23.50%-23.45%
-47.23%-33.10%
Max drawdown duration
PSCH
XPH
79d14d
242d140d
449d322d
1718d1706d
Trading data

Create an account to view trading data

Join for free
PSCH
XPH
Last sale
3/12/2026 at 1:30 PM
$39.81
$53.64
Previous close
03/11/2026
$41.15
$55.49
Consolidated volume
03/11/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of February 27, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
PSCH
XPH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 3/12/2026 at 1:30 PM
Live
Closed
PSCH
XPH
Last price
$39.81
$53.64
1D performance
-3.26%
-3.33%
AuM$124.38 M$313.37 M
E/R0.29%0.35%
Characteristics
PSCH
XPH
Management strategyPassivePassive
ProviderInvescoSPDR
BenchmarkS&P SmallCap 600 Capped Health Care IndexS&P Pharmaceuticals Select Industry Index
N° of holdings7149
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateApril 7, 2010June 19, 2006
ESGNoNo
Advertisement
Exposure

Countries

PSCH
USA
95.98%
Other
4.02%
XPH
USA
85.59%
Other
14.41%

Sectors

PSCH
Health Care
91.17%
Other
8.83%
XPH
Health Care
81.97%
Other
18.03%
Advertisement

Diversification

PSCH

Total weight of top 15 holdings out of 15

43.5%
XPH

Total weight of top 15 holdings out of 15

32.4%

Top 15 holdings

Data as of January 31, 2026
PSCH
ARROWHEAD PHARMACEUTICALS INC
4.98%
KRYSTAL BIOTECH INC
3.88%
GLAUKOS
3.85%
PTC THERAPEUTI/D
3.30%
ALKERMES
2.95%
RADNET
2.78%
MERIT MEDICAL SYSTEMS
2.64%
PROTAGONIST THERAPEUTICS INC
2.61%
TRANSMEDICS GROUP
2.57%
TELEFLEX
2.48%
US10950A1060
2.46%
CORCEPT THERAPEUTICS
2.31%
US45579U1097
2.26%
TG THERAPEUTICS
2.25%
ADMA BIOLOGICS INC
2.18%
XPH
LIQUIDIA CORPORATION
2.45%
US55287L1017
2.41%
AXSOME THERA CMN STK
2.33%
ORGANON & CO
2.25%
EDGEWISE THERAPEUTICS
2.24%
ELANCO ANIMAL HEALTH INC
2.13%
MERCK & CO INC
2.13%
VIATRIS INC
2.13%
AMNEAL PHARMACEUTICALS INC
2.12%
JOHNSON&JOHNSON
2.08%
ROYALTY PHARMA
2.06%
AMYLYX PHARMACEUTICALS
2.04%
BRISTOL-MYERS SQUIBB
2.03%
XERIS BIOPHARMA HOLDINGS INC
2.00%
ZOETIS INC
2.00%
Frequently asked questions about PSCH and XPH

How have the PSCH and XPH ETFs performed in 2026?

As of March 11, 2026, PSCH is down -6.58% year-to-date (YTD), while XPH has lost -1.12%. That puts XPH better performer ahead so far this year.

Which ETF is attracting more investor money: PSCH or XPH?

Year-to-date, the PSCH ETF saw -$14M in flows, compared to +$88M for XPH.

Which ETF is more volatile: PSCH or XPH?

Over the past year, PSCH had a volatility of 23%, while XPH experienced 23.08%.

Which ETF is bigger: PSCH or XPH?

As of March 11, 2026, PSCH holds $124.38 M in assets under management (AUM), while XPH manages $313.37 M.

What sectors do the PSCH and XPH ETFs invest in?

PSCH leans toward sectors like Health Care. Meanwhile, XPH focuses on Health Care.

What are the top holdings of the PSCH ETF and XPH ETF?

PSCH top holdings include ARROWHEAD PHARMACEUTICALS INC, KRYSTAL BIOTECH INC and GLAUKOS. XPH holds in its top three: LIQUIDIA CORPORATION, US55287L1017 and AXSOME THERA CMN STK.

Which ETF is more diversified: PSCH or XPH?

PSCH holds 75 securities with 43.5% of its assets in the top 15. XPH has 57 securities and a top 15 weight of 32.4%.

Advertisement
Advertisement
Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up